These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


436 related items for PubMed ID: 32716319

  • 1. Management of Orthostatic Hypotension in Parkinson's Disease.
    Fanciulli A, Leys F, Falup-Pecurariu C, Thijs R, Wenning GK.
    J Parkinsons Dis; 2020; 10(s1):S57-S64. PubMed ID: 32716319
    [Abstract] [Full Text] [Related]

  • 2. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
    Kuritzky L, Espay AJ, Gelblum J, Payne R, Dietrich E.
    Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731
    [Abstract] [Full Text] [Related]

  • 3. Orthostatic hypotension in Parkinson's disease: Sit-to-stand vs. supine-to-stand protocol and clinical correlates.
    Lim KB, Lim SY, Hor JW, Krishnan H, Mortadza F, Lim JL, Chinna K, Saedon NI, Tan AH.
    Parkinsonism Relat Disord; 2024 Jun; 123():106980. PubMed ID: 38657381
    [Abstract] [Full Text] [Related]

  • 4. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.
    Isaacson SH, Skettini J.
    Vasc Health Risk Manag; 2014 Jun; 10():169-76. PubMed ID: 24729712
    [Abstract] [Full Text] [Related]

  • 5. Orthostatic hypotension in Parkinson's disease: Does it matter if asymptomatic?
    Merola A, Romagnolo A, Rosso M, Lopez-Castellanos JR, Wissel BD, Larkin S, Bernardini A, Zibetti M, Maule S, Lopiano L, Espay AJ.
    Parkinsonism Relat Disord; 2016 Dec; 33():65-71. PubMed ID: 27641792
    [Abstract] [Full Text] [Related]

  • 6. Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.
    Espay AJ, LeWitt PA, Hauser RA, Merola A, Masellis M, Lang AE.
    Lancet Neurol; 2016 Aug; 15(9):954-966. PubMed ID: 27478953
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and treatment of orthostatic hypotension.
    Wieling W, Kaufmann H, Claydon VE, van Wijnen VK, Harms MPM, Juraschek SP, Thijs RD.
    Lancet Neurol; 2022 Aug; 21(8):735-746. PubMed ID: 35841911
    [Abstract] [Full Text] [Related]

  • 8. Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.
    Baker J, Kimpinski K.
    CNS Drugs; 2017 Aug; 31(8):653-663. PubMed ID: 28702747
    [Abstract] [Full Text] [Related]

  • 9. Dysautonomia: A Forgotten Condition - Part 1.
    Rocha EA, Mehta N, Távora-Mehta MZP, Roncari CF, Cidrão AAL, Elias Neto J.
    Arq Bras Cardiol; 2021 Apr; 116(4):814-835. PubMed ID: 33886735
    [Abstract] [Full Text] [Related]

  • 10. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial.
    Schreglmann SR, Büchele F, Sommerauer M, Epprecht L, Kägi G, Hägele-Link S, Götze O, Zimmerli L, Waldvogel D, Baumann CR.
    Eur J Neurol; 2017 Apr; 24(4):545-551. PubMed ID: 28224720
    [Abstract] [Full Text] [Related]

  • 11. [Orthostatic hypotension in patients with Parkinson's disease].
    Zalyalova ZA, Khasanova DM, Ilina GR.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023 Apr; 123(6):16-21. PubMed ID: 37382973
    [Abstract] [Full Text] [Related]

  • 12. Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report.
    Mobarek SK.
    BMC Cardiovasc Disord; 2020 Feb 04; 20(1):54. PubMed ID: 32019498
    [Abstract] [Full Text] [Related]

  • 13. [Intractable Orthostatic Hypotension in Patients with Parkinson's Disease: Early Diagnosis and Treatment Strategies].
    Tsuboi Y.
    Brain Nerve; 2022 May 04; 74(5):708-713. PubMed ID: 35589667
    [Abstract] [Full Text] [Related]

  • 14. Orthostatic hypotension: evaluation and treatment.
    Maule S, Papotti G, Naso D, Magnino C, Testa E, Veglio F.
    Cardiovasc Hematol Disord Drug Targets; 2007 Mar 04; 7(1):63-70. PubMed ID: 17346129
    [Abstract] [Full Text] [Related]

  • 15. Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease.
    Shibao CA, Kaufmann H.
    CNS Drugs; 2017 Nov 04; 31(11):975-989. PubMed ID: 29076058
    [Abstract] [Full Text] [Related]

  • 16. Management of neurogenic orthostatic hypotension.
    Arbique D, Cheek D, Welliver M, Vongpatanasin W.
    J Am Med Dir Assoc; 2014 Apr 04; 15(4):234-9. PubMed ID: 24388946
    [Abstract] [Full Text] [Related]

  • 17. Advice to People with Parkinson's in My Clinic: Orthostatic Hypotension.
    Lamotte G, McKee KE, Luthra NS, Corcos DM.
    J Parkinsons Dis; 2024 Apr 04; 14(6):1139-1146. PubMed ID: 39093080
    [Abstract] [Full Text] [Related]

  • 18. Supine hypertension: A state of the art.
    Mantovani G, Marozzi I, Rafanelli M, Rivasi G, Volpato S, Ungar A.
    Auton Neurosci; 2022 Sep 04; 241():102988. PubMed ID: 35613491
    [Abstract] [Full Text] [Related]

  • 19. Orthostatic hypotension due to autonomic disorders in the hypertension clinic.
    Mansoor GA.
    Am J Hypertens; 2006 Mar 04; 19(3):319-26. PubMed ID: 16500521
    [Abstract] [Full Text] [Related]

  • 20. [Orthostatic hypotension and supine hypertension in pure autonomic failure].
    Sartori M, Pessina AC.
    Ital Heart J Suppl; 2004 Nov 04; 5(11):879-83. PubMed ID: 15633433
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.